Back to search results

Genesis Electrical Impedance Tomography (EIT) Study for Respiratory Conditions

This study is looking at a new imaging system called Genesis Electrical Impedance Tomography (EIT). EIT is a way to see how your lungs are working without using radiation, by reading through electrodes placed on your body. Researchers want to see how well EIT works in children and young adults with breathing problems like bronchopulmonary dysplasia (BPD, a chronic lung condition often affecting premature babies) or those with neuromuscular diseases that affect breathing. They are also including healthy people for comparison. The main goal is to see if EIT can create maps of your lungs that show how air and blood are moving through them. You might be able to join if you are between 2 weeks and 40 years old and have BPD, a chronic respiratory disease due to a neuromuscular condition, or a confirmed neuromuscular disease.

Study design
This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It plans to include up to 90 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main results will be measured at 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03797183

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Recruiting
Not specifiedAges 14–40Observational
University of Colorado, Denver
~90 participants
Updated 2025-11-13 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
EIT imaging maps that provide regional information regarding ventilation and perfusion of the lung.
Measured over 24 months

Conditions

Premature Infant
Chronic Respiratory Disease
Neuromuscular Diseases
Healthy
Bronchopulmonary Dysplasia
Pulmonary Vein Stenoses

Explore related trials

Bronchopulmonary DysplasiaHealthyNeuromuscular DisorderPremature infantPulmonary Artery StenosisPulmonary HypertensionPulmonary Vein Stenosis

Where it's being run

1 sites across 1 states
Colorado1

Who to contact

Emily DeBoer, MD
[email protected]
720-777-4953
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

2 weeks old - 40 years old
Premature infants with current age \>2 weeks with a confirmed diagnosis of BPD based on NIH criteria
Or Chronic respiratory disease due to underlying neuromuscular disease
Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
have had a VQ scan
will be undergoing cardiac catherization for for pulmonary vein stenosis, pulmonary hypertension and/or pulmonary artery stenosis
Or healthy controls

Exclusion

\<2 weeks of age
Congenital diaphragmatic hernia
Severe congenital heart disease
Significant genetic abnoralities
Anything that interferes with lead placement on the chest wall
Unwilling/refusal to sign consent
Pregnant or lactating
Pacemaker of other surgical implant and spinal implant (causes noise in the data)
Moderate to severe cardiomyopathy
Patients with temporary cognitive disability due to illness

What this trial measures

  • EIT imaging maps that provide regional information regarding ventilation and perfusion of the lung.24 months

    These images will be analyzed both visually for qualitative abnormalities and through quantitative pixel analysis that can provide information regarding lung volume, blood volume, and changes in either based on respiratory cycle, cardiac cycle, or intervention. Areas of low ventilation (atelectasis and consolidation) will be identified.